Cargando…

Fludarabine Modulates Immune Response and Extends In Vivo Survival of Adoptively Transferred CD8 T Cells in Patients with Metastatic Melanoma

BACKGROUND: Adoptive T cell therapy involving the use of ex vivo generated antigen-specific cytotoxic T lymphocytes provides a promising approach to immunotherapy. It has become increasingly apparent that anti-tumor efficacy using adoptively transferred T cells is linked to their duration of in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallen, Herschel, Thompson, John A., Reilly, J. Zachary, Rodmyre, Rebecca M., Cao, Jianhong, Yee, Cassian
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650617/ https://www.ncbi.nlm.nih.gov/pubmed/19270751 http://dx.doi.org/10.1371/journal.pone.0004749

Ejemplares similares

Adoptively transferred melanoma-reactive CTL primed in the presence of IL-21 and transferred with concurrent CTLA4 blockade results in enhanced CTL persistence and tumor regression
por: Yee, Cassian, et al.
Publicado: (2014)

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha
por: Verdegaal, Els M. E., et al.
Publicado: (2011)

Polyfunctional incompletely differentiated CD8+ T cells accumulates after adoptive transfer of tumor-infiltrating lymphocytes and establish immunological memory in patients with metastatic melanoma
por: Donia, Marco, et al.
Publicado: (2015)

Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
por: Yee, Cassian
Publicado: (2005)

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
por: Saberian, Chantal, et al.
Publicado: (2021)

Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer
por: Bear, Adham S., et al.
Publicado: (2013)

Focus on Adoptive T Cell Transfer Trials in Melanoma
por: Hershkovitz, Liat, et al.
Publicado: (2010)

Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model
por: Contreras, Amanda, et al.
Publicado: (2018)

Interaction between effector and memory cd8+ t cells enhances melanoma adoptive immunotherapy
por: Contreras, Amanda, et al.
Publicado: (2015)

Adoptive Transfer of siRNA Cblb-Silenced CD8(+) T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model
por: Hinterleitner, Reinhard, et al.
Publicado: (2012)

B cells imprint adoptively transferred CD8(+) T cells with enhanced tumor immunity
por: Smith, Aubrey S, et al.
Publicado: (2022)

Is there a future for adoptive cell transfer in melanoma patients?
por: Besser, Michal J
Publicado: (2013)

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
por: Krimphove, Marieke J., et al.
Publicado: (2019)

Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies
por: Besser, Michal J., et al.
Publicado: (2013)

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients
por: Dréno, Brigitte, et al.
Publicado: (2021)

Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders
por: Cassano, Carlos, et al.
Publicado: (2010)

Isolation of adoptively transferred CD8(+) T cells in mouse tumor tissues for lipid peroxidation detection
por: Xiao, Liuling, et al.
Publicado: (2022)

Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
por: Bug, Gesine, et al.
Publicado: (2023)

Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient
por: Chapuis, Aude G., et al.
Publicado: (2016)

Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+ T Cells Reduces Melanoma Growth in Mice
por: Montinaro, Antonella, et al.
Publicado: (2012)

Effect of adoptive transfer of CD4, CD8 and B cells on recovery from MHV3-induced immunodeficiencies.
por: Lamontagne, L, et al.
Publicado: (1996)

Neurological illness following treatment with fludarabine.
por: Johnson, P. W., et al.
Publicado: (1994)

[(18)F]-Fludarabine for Hematological Malignancies
por: Barré, Louisa, et al.
Publicado: (2019)

Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
por: Hinrichs, Christian S, et al.
Publicado: (2013)

PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8(+) T Cells
por: Bowers, Jacob S., et al.
Publicado: (2017)

Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2016)

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission
por: Saraceni, Francesco, et al.
Publicado: (2017)

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8(+) T cells
por: Gattinoni, Luca, et al.
Publicado: (2005)

Formation of a Unique Population of CD8+ T Lymphocytes after Adoptive Transfer of Syngeneic Splenocytes to Mice with Lymphopenia
por: Silaeva, Yu. Yu., et al.
Publicado: (2021)

Durable complete response in a patient with metastatic melanoma following adoptive transfer of autologous T cells recognizing 10 mutated tumor antigens
por: Prickett, Todd D, et al.
Publicado: (2015)

Neoantigen-reactive CD8(+) T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
por: Kristensen, Nikolaj Pagh, et al.
Publicado: (2022)

Expansion of Melanoma-specific Cytolytic CD8(+) T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34(+) Progenitor-derived Dendritic Cells
por: Paczesny, Sophie, et al.
Publicado: (2004)

Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
por: Khammari, Amir, et al.
Publicado: (2014)

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
por: Rohaan, Maartje W., et al.
Publicado: (2018)

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
por: Borch, Troels Holz, et al.
Publicado: (2020)

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma
por: van Vliet, Amanda A., et al.
Publicado: (2021)

Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+ )T lymphocytes
por: von Euw, Erika M, et al.
Publicado: (2007)

The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells
por: Lisiero, Dominique N, et al.
Publicado: (2014)

Adoptive Transfer of EBV Specific CD8(+) T Cell Clones Can Transiently Control EBV Infection in Humanized Mice
por: Antsiferova, Olga, et al.
Publicado: (2014)

Adoptive Transfer of Interleukin-21-stimulated Human CD8(+) T Memory Stem Cells Efficiently Inhibits Tumor Growth
por: Chen, Yingshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_69cjopcg88db5jb6e2n8jmkn9r